Renal Cell Carcinoma News

RENAL CELL CARCINOMA ADVISOR

Renal Cell Carcinoma News

Bevacizumab Biosimilar Alymsys Gets FDA Approval

The approval was based on data demonstrating that the biosimilar product and the reference product were highly similar, and that there were no clinically meaningful differences between the agents.